Partners and collaborators include the University of Pennsylvania, Merck, NIH, HIV
Vaccines Trial Network, National Cancer Institute, U.S. Military HIV Research
Program, University of Southampton, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.
For further information:
Emilie Vincent, Head of Roche Partnering Communications, emilie.